A Phase 1/2 Open-Label, Single Ascending Dose Trial of a

Project: Research project

Project Details

Description

A Phase 1/2 Open-Label, Single Ascending Dose Trial of a Self-Complementing Optimized Adenoassociated Virus Serotype 8 Factor IX Gene Therapy (AskBio009) in Adults with Hemophilia B
StatusFinished
Effective start/end date5/30/125/30/17

Funding

  • ASKLEPIOS Biopharmaceutical, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.